The Source Blog
Trends in Price and Quality Transparency
All Payer Claims Databases (APCD)
For more on APCD’s, check out our Legislative Topics: All Payer Claims Databases overview on Medium.
-
Key:
- Implementing APCD
- Investigating APCD
Pharmaceutical Price Transparency Legislation
For more on this legislation, refer to our Issue Brief on The Source Blog and the NASHP Center for Rx Pricing.
-
Key:
- Price Transparency Legislation
Recent Action in Price and Quality Transparency
A 10026 (see companion bill S 8384) – New York
Introduced: 2018 Status: Inactive / Dead
PHARMACY BENEFIT MANAGER TRANSPARENCY ACT: A pharmacy benefit manager shall notify a covered entity in writing of any activity, policy, practice, ownership, interest, or affiliation of the pharmacy benefit manager that presents a conflict on …
S 8384 (see companion bill A 10026) – New York
Introduced: 2018 Status: Inactive / Dead
PHARMACY BENEFIT MANAGER TRANSPARENCY ACT: A pharmacy benefit manager shall notify a covered entity in writing of any activity, policy, practice, ownership, interest, or affiliation of the pharmacy benefit manager that presents a conflict on …
SB 46 – West Virginia
Introduced: 2018 Status: Enacted
THE PHARMACY AUDIT INTEGRITY AND TRANSPARENCY ACT. This law provides that a pharmacy, pharmacist, or pharmacy technician may inform consumers of lower cost alternatives and cost share to assist health care consumers in making informed …
HB 436 – Louisiana
Introduced: 2018 Status: Enacted
PROVIDES RELATIVE TO THE REGULATION OF PHARMACY BENEFIT MANAGERS: Prohibits PBM network contract provisions that prohibit pharmacist from disclosing any relevant information to a consumer, including but not limited to the cost of the prescription …
HB 5858 – Michigan
Introduced: 2018 Status: Inactive / Dead
CONTRACT PROVISION ALLOWING A PHARMACY TO DISCLOSE CURRENT DRUG PRICES TO A CONSUMER: A contract between a pharmacy benefit manager and a pharmacy must provide that the pharmacy may disclose the current selling price of …
Next | See all Legislation Records
Introduced: 2018 Status: Inactive / Dead
PHARMACY BENEFIT MANAGER TRANSPARENCY ACT: A pharmacy benefit manager shall notify a covered entity in writing of any activity, policy, practice, ownership, interest, or affiliation of the pharmacy benefit manager that presents a conflict on …
S 8384 (see companion bill A 10026) – New York
Introduced: 2018 Status: Inactive / Dead
PHARMACY BENEFIT MANAGER TRANSPARENCY ACT: A pharmacy benefit manager shall notify a covered entity in writing of any activity, policy, practice, ownership, interest, or affiliation of the pharmacy benefit manager that presents a conflict on …
SB 46 – West Virginia
Introduced: 2018 Status: Enacted
THE PHARMACY AUDIT INTEGRITY AND TRANSPARENCY ACT. This law provides that a pharmacy, pharmacist, or pharmacy technician may inform consumers of lower cost alternatives and cost share to assist health care consumers in making informed …
HB 436 – Louisiana
Introduced: 2018 Status: Enacted
PROVIDES RELATIVE TO THE REGULATION OF PHARMACY BENEFIT MANAGERS: Prohibits PBM network contract provisions that prohibit pharmacist from disclosing any relevant information to a consumer, including but not limited to the cost of the prescription …
HB 5858 – Michigan
Introduced: 2018 Status: Inactive / Dead
CONTRACT PROVISION ALLOWING A PHARMACY TO DISCLOSE CURRENT DRUG PRICES TO A CONSUMER: A contract between a pharmacy benefit manager and a pharmacy must provide that the pharmacy may disclose the current selling price of …
Next | See all Legislation Records
Pharmaceutical Care Management v. Rutledge – Arkansas
District Court: Eastern District of Arkansas Status: Decided
The 8th Circuit held that both ERISA and Medicare Part D preempted Arkansas’ drug pricing law Act 900 (SB 688). Act 900 requires disclosure of …
PhRMA v. Brown – California
District Court: Eastern District of California Status: Pending
PhRMA is challenging California’s drug price transparency law SB 17 alleging that the law is unconstitutional because it violates the Commerce Clause, the First Amendment, …
Association for Accessible Medicines v. Frosh – Maryland
District Court: District of Maryland Status: Decided
In a significant victory for the pharmaceutical industry, the 4th U.S. Circuit Court of Appeals found Maryland’s landmark 2017 law (HB 631), which punishes generic …
PhRMA and BIO v. Sandoval – Nevada
District Court: District of Nevada Status: Decided
PhRMA and BIO brought the lawsuit against the state after Gov. Brian Sandoval signed SB 539 in June 2017 to increase transparency over the price …
See all Litigation Records
District Court: Eastern District of Arkansas Status: Decided
The 8th Circuit held that both ERISA and Medicare Part D preempted Arkansas’ drug pricing law Act 900 (SB 688). Act 900 requires disclosure of …
PhRMA v. Brown – California
District Court: Eastern District of California Status: Pending
PhRMA is challenging California’s drug price transparency law SB 17 alleging that the law is unconstitutional because it violates the Commerce Clause, the First Amendment, …
Association for Accessible Medicines v. Frosh – Maryland
District Court: District of Maryland Status: Decided
In a significant victory for the pharmaceutical industry, the 4th U.S. Circuit Court of Appeals found Maryland’s landmark 2017 law (HB 631), which punishes generic …
PhRMA and BIO v. Sandoval – Nevada
District Court: District of Nevada Status: Decided
PhRMA and BIO brought the lawsuit against the state after Gov. Brian Sandoval signed SB 539 in June 2017 to increase transparency over the price …
See all Litigation Records
News & Opinions
Articles & Reports
Health Affairs Blog
September 25, 2018
Kaiser Family Foundation September 5, 2018
Health Affairs September 4, 2018
Brigham Young University Law Review August 31, 2018
Kaiser Family Foundation September 5, 2018
Health Affairs September 4, 2018
Brigham Young University Law Review August 31, 2018